Haim Danenberg

Title: Haim Danenberg: Innovator in Vascular Restenosis Treatment

Introduction

Haim Danenberg is a notable inventor based in Brookline, MA (US). He has made significant contributions to the field of medical technology, particularly in the treatment of vascular restenosis. With a total of 2 patents, Danenberg's work focuses on innovative methods to inhibit the activity of cytokines and growth factors associated with this condition.

Latest Patents

Danenberg's latest patents include a "Method of inhibiting restenosis using bisphosphonates" and a "Method of treating restenosis using bisphosphonate nanoparticles." The first patent describes a method that involves administering an effective amount of bisphosphonate particles to inhibit the activity or production of cytokines or growth factors linked to vascular restenosis. The bisphosphonates can be encapsulated, embedded, or adsorbed within various types of particles, including liposomes and inert polymeric particles. The second patent outlines a similar approach, focusing on the treatment or prevention of restenosis by using bisphosphonate particulates to inhibit the growth and proliferation of cell types involved in the restenotic cascade.

Career Highlights

Haim Danenberg is associated with the Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. His work has been instrumental in advancing the understanding and treatment of vascular conditions, showcasing his commitment to medical innovation.

Collaborations

Danenberg collaborates with Gershon Golomb, further enhancing the research and development efforts in their field.

Conclusion

Haim Danenberg's contributions to the treatment of vascular restenosis through innovative methods highlight his role as a key inventor in medical technology. His patents reflect a dedication to improving patient outcomes and advancing scientific knowledge.